DE69629808D1 - Promtors für gen expression - Google Patents

Promtors für gen expression

Info

Publication number
DE69629808D1
DE69629808D1 DE69629808T DE69629808T DE69629808D1 DE 69629808 D1 DE69629808 D1 DE 69629808D1 DE 69629808 T DE69629808 T DE 69629808T DE 69629808 T DE69629808 T DE 69629808T DE 69629808 D1 DE69629808 D1 DE 69629808D1
Authority
DE
Germany
Prior art keywords
promoters
promtors
region
promoter
gen expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629808T
Other languages
English (en)
Other versions
DE69629808T2 (de
Inventor
A Lagosky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire NPS Pharmaceuticals Inc
Original Assignee
NPS Allelix Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NPS Allelix Corp Canada filed Critical NPS Allelix Corp Canada
Application granted granted Critical
Publication of DE69629808D1 publication Critical patent/DE69629808D1/de
Publication of DE69629808T2 publication Critical patent/DE69629808T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69629808T 1995-05-19 1996-05-16 Promotoren für Gen Expression Expired - Lifetime DE69629808T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/445,133 US5629205A (en) 1995-05-19 1995-05-19 Promoters for gene expression
US445133 1995-05-19
PCT/IB1996/000462 WO1996036721A1 (en) 1995-05-19 1996-05-16 Promoters for gene expression

Publications (2)

Publication Number Publication Date
DE69629808D1 true DE69629808D1 (de) 2003-10-09
DE69629808T2 DE69629808T2 (de) 2004-07-15

Family

ID=23767732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629808T Expired - Lifetime DE69629808T2 (de) 1995-05-19 1996-05-16 Promotoren für Gen Expression

Country Status (25)

Country Link
US (1) US5629205A (de)
EP (1) EP0828844B1 (de)
JP (2) JP3828576B2 (de)
KR (1) KR19990014906A (de)
CN (1) CN1131313C (de)
AT (1) ATE248923T1 (de)
AU (1) AU698656B2 (de)
BR (1) BR9609102A (de)
CA (1) CA2221587C (de)
CZ (1) CZ357997A3 (de)
DE (1) DE69629808T2 (de)
DK (1) DK0828844T3 (de)
EE (1) EE9700355A (de)
ES (1) ES2202436T3 (de)
HK (1) HK1004148A1 (de)
HU (1) HUP9900750A3 (de)
IS (1) IS4609A (de)
MX (1) MX9708689A (de)
NO (1) NO325879B1 (de)
NZ (1) NZ306536A (de)
PL (1) PL324226A1 (de)
PT (1) PT828844E (de)
SK (1) SK154997A3 (de)
TR (1) TR199701394T1 (de)
WO (1) WO1996036721A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194168B1 (en) 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
EP1572720A4 (de) * 2002-05-24 2008-12-24 Nps Allelix Corp Verfahren zur enzymatischen herstellung von glp-2-(1-33)- und glp-2-(1-34)-peptiden
US20050119183A1 (en) * 2003-11-12 2005-06-02 Nps Allelix Corp. Method for treating bone loss using parathyroid hormone
DK1704234T3 (da) * 2003-11-21 2012-05-07 Nps Pharma Inc Fremstilling af glucagon-lignende peptid 2 og analoger
WO2005058946A2 (en) * 2003-12-12 2005-06-30 Zymogenetics, Inc. Methods for enhancing expression of recombinant proteins
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
KR102606210B1 (ko) 2017-04-27 2023-11-24 주노 테라퓨틱스 게엠베하 올리고머 입자 시약 및 이의 사용 방법
CN108060168B (zh) * 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108165551B (zh) * 2017-12-30 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108118059B (zh) * 2017-12-30 2021-03-19 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的载体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517071D0 (en) * 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
ATE123526T1 (de) * 1987-08-17 1995-06-15 Hoffmann La Roche Hochreprimierbare expressionskontrollsequenzen.
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
JPH05509001A (ja) * 1990-08-28 1993-12-16 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー 有効な分泌用ベクター類の迅速選択方法

Also Published As

Publication number Publication date
CA2221587C (en) 2008-07-08
KR19990014906A (ko) 1999-02-25
NO325879B1 (no) 2008-08-11
BR9609102A (pt) 1999-05-11
CN1190993A (zh) 1998-08-19
IS4609A (is) 1997-11-07
CA2221587A1 (en) 1996-11-21
HK1004148A1 (en) 1998-11-20
AU5511696A (en) 1996-11-29
JP3828576B2 (ja) 2006-10-04
EE9700355A (et) 1998-06-15
HUP9900750A3 (en) 1999-11-29
US5629205A (en) 1997-05-13
AU698656B2 (en) 1998-11-05
ES2202436T3 (es) 2004-04-01
PL324226A1 (en) 1998-05-11
DE69629808T2 (de) 2004-07-15
DK0828844T3 (da) 2004-01-05
ATE248923T1 (de) 2003-09-15
JP3837154B2 (ja) 2006-10-25
JP2006187295A (ja) 2006-07-20
TR199701394T1 (xx) 1998-02-21
NO975286D0 (no) 1997-11-18
EP0828844A1 (de) 1998-03-18
EP0828844B1 (de) 2003-09-03
SK154997A3 (en) 1998-05-06
NZ306536A (en) 1999-10-28
NO975286L (no) 1997-11-18
CZ357997A3 (cs) 1998-04-15
PT828844E (pt) 2004-01-30
MX9708689A (es) 1998-02-28
JPH11509083A (ja) 1999-08-17
CN1131313C (zh) 2003-12-17
HUP9900750A2 (hu) 1999-06-28
WO1996036721A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
AU8131294A (en) Human kunitz-type protease inhibitors
BG102612A (en) Complementary adenoviral vector systems and cellular lines
BR9608149A (pt) Variante de subtilase processos para efetuar a mutação no dna que codifica uma enzima de subtilase para a manufatura de uma enzima de subtilase mutante e para produzir a variante sequência de dna vetor e hospedeiro microbiano
DE69634412D1 (de) Regulierte gene und ihre verwendungen
DE69629808D1 (de) Promtors für gen expression
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
AU2002230691A1 (en) Putrescine-n-methyltransferase promoter
WO1994012637A3 (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
ATE297750T1 (de) Verwendung von hsp70 protein
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
DK0877758T3 (da) Oprenset SR-p70-protein
DK1097233T3 (da) Promotor for vækstdifferentieringsfaktor og anvendelser deraf
DE59712554D1 (de) Rekombinante expression von s-layer-proteinen
FI946076A (fi) Modifioituja Kluyveromyces-hiivoja, valmistus ja käyttö
FI951633A (fi) Erittyvien proteiinien lisääntynyt tuotanto eukaryoottisilla yhdistelmäsoluilla
ATE356212T1 (de) O-fukosyltransferase
AU571559B2 (en) Alpha-allenic-alpha amino acids
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: NPS PHARMACEUTICALS,INC., BEDMINSTER, N.J., US